Phage Therapy for Respiratory infecitons

Combating drug-resistant pathogens, especially in respiratory infections, is critical in modern healthcare. Conditions like bronchiectasis, pneumonia, cystic fibrosis, and hospital-acquired pneumonia are increasingly difficult to treat due to antibiotic resistance. Bronchiectasis involves the permanent enlargement of parts of the airways, leading to mucus buildup and infections. Pneumonia is an infection that inflames the air sacs in one or both lungs, causing difficulty breathing. Cystic fibrosis is a genetic disorder that leads to severe respiratory and digestive problems due to thick, sticky mucus. Hospital-acquired pneumonia occurs in hospitalized patients, often with antibiotic-resistant bacteria. Innovative treatments like our phage cocktails are essential to effectively combat these infections, improve patient outcomes, reduce healthcare costs, and prevent the spread of resistant strains.

Our groundbreaking discoveries will introduce innovative technologies for the prevention and treatment of respiratory infections using natural products.